Caption Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-211,100
Closed -$48.9M 1518
2025
Q3
$48.9M Buy
+211,100
New +$43M 0.38% 46
2025
Q1
Sell
-222,200
Closed -$39.5M 1444
2024
Q4
$39.5M Buy
222,200
+172,200
+344% +$31.7M 0.37% 40
2024
Q3
$9.87M Hold
50,000
0.16% 156
2024
Q2
$8.58M Hold
50,000
0.13% 171
2024
Q1
$9.11M Sell
50,000
-55,000
-52% -$9.48M 0.14% 185
2023
Q4
$16.3M Buy
105,000
+50,000
+91% +$7.29M 0.22% 115
2023
Q3
$8.2M Hold
55,000
0.13% 193
2023
Q2
$7.41M Buy
55,000
+15,000
+38% +$2.2M 0.13% 201
2023
Q1
$6.37M Buy
+40,000
New +$6.12M 0.12% 192
2022
Q3
Sell
-126,900
Closed -$19.4M 1458
2022
Q2
$19.4M Buy
126,900
+63,400
+100% +$9.69M 0.27% 84
2022
Q1
$10.3M Sell
63,500
-136,500
-68% -$19.8M 0.12% 209
2021
Q4
$27.1M Buy
200,000
+100,000
+100% +$11.8M 0.3% 62
2021
Q3
$10.8M Buy
+100,000
New +$11.4M 0.12% 219
2021
Q1
Sell
-86,900
Closed -$9.31M 993
2020
Q4
$9.31M Buy
86,900
+24,800
+40% +$2.38M 0.21% 130
2020
Q3
$5.44M Sell
62,100
-21,900
-26% -$2.06M 0.13% 201
2020
Q2
$8.25M Buy
+84,000
New +$7.4M 0.27% 87
2019
Q3
Sell
-40,000
Closed -$2.91M 681
2019
Q2
$2.91M Sell
40,000
-25,000
-38% -$1.96M 0.15% 192
2019
Q1
$5.24M Buy
+65,000
New +$5.32M 0.29% 102

Other funds holding ABBV

Caption Management's ABBV Position: Q1 2026 in Review

Caption Management increased its AbbVie (ABBV) stake by 109% in Q1 2026, buying an estimated $3.9M and bringing the position to 33,700 shares worth $7.33M. The position accounts for 0.04% of the portfolio, ranked #417.

Caption Management first reported a position in ABBV in Q1 2019 and has held it in 8 quarters since. The position peaked at $10.2M in Q4 2021. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Caption Management held 33,700 shares of AbbVie worth $7.33M as of Q1 2026.
  • Caption Management bought 17,600 AbbVie shares in Q1 2026, an estimated $3.9M.
  • AbbVie made up 0.04% of Caption Management's portfolio in Q1 2026, its #417 holding.
  • Caption Management first reported a position in AbbVie in Q1 2019 and has held it in 8 quarters since.
  • Caption Management's AbbVie position peaked at $10.2M in Q4 2021.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.